In the next 12 months FDA plans to write safety standards for e-liquids and establish regulations for detaining tobacco products believed to be misbranded during inspections, according to the agency's spring 2018 regulatory agenda. While the new agenda includes fewer than 10 regulations that have not been included in previous plans, it does provide some new insights into the timeline for releasing anticipated regulations on compounding, patient medication information and increased access to nonprescription drugs. FDA plans to issue a...